A study of regulations combating counterfeit medicines across India, USA, and Europe

被引:0
|
作者
Nori, Lakshmi Prasanthi [1 ]
Varma, T. Srinivas [1 ]
Nulu, Lakshmi Sri Naga Valli [1 ]
Raju, K. Venkateswara [1 ]
机构
[1] Shri Vishnu Coll Pharm, Dept Regulatory Affairs, Bhimavaram, Andhra Pradesh, India
关键词
Blockchain; counterfeit; customs and board protection; falsified; pharmaceutical; serialization; spurious/falsely labeled/falsified/counterfeit;
D O I
10.4103/ajprhc.ajprhc_39_23
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Counterfeiting is the deliberate and fraudulent production of products including mislabeling in attempts to deliberately morph its identity and source for making its appearance as genuine and as it is concerning the original product. Counterfeit medicines are pharmaceutical medicinal products without anyActive pharmaceutical ingredient (API), substandard quality API, or a fraction of the original amount of API stated as a different API, cross-contaminated API, and expiry products that are repacked including formulations done incorrectly and produced in substandard conditions. Expensive drug's extensive demand like steroids, antibiotics, cancer-treating drugs, vaccines, antivirals, and antihistamines are targets for counterfeiting. Patients deceived into buying counterfeit drugs are people seeking to buy discounted medications and involved in inappropriate usage. With identical labels as well as nearly resemblance to originals, these counterfeits are cheaper to make. Counterfeit medicines kill and threaten the lives of abused patients, fooled by false appearances. Medicines and health-care items are different from other commodities, and their fakes are different from other fakes. They are deceived by misleading characteristics and harm and risk the lives of several mistreated victims daily. This variety of terms and definitions, which might differ from one nation to the next, leads to a lack of awareness of the issue on a worldwide scale. The European Union's mainly prefers the term "counterfeiting," lately the phrase "falsification" even if the US uses the phrase "false" or "fake" more. We must comprehend the phrase "medicine" and its meanings to define the many terminologies used to describe counterfeiting.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 50 条
  • [21] ESMO EUROPEAN CONSORTIUM STUDY ON THE AVAILABILITY OF ANTI-NEOPLASTIC MEDICINES ACROSS EUROPE
    Cherny, N. I.
    Eniu, A.
    Sullivan, R.
    Saar, M.
    Torode, J.
    Ullrich, A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [22] Navigating the Regulatory Landscape: Key Transformations in India's Drug & Clinical Trials Regulations - A Comparative Analysis with the USA & Europe
    Trivedi, Dhara
    Thummar, Kashyap
    Maheriya, Bhumika
    Chauhan, Sanjay
    ADVANCES IN PHARMACOLOGY AND PHARMACY, 2025, 13 (02) : 204 - 213
  • [23] EVALUATION OF COUNTERFEIT MEDICINES AVAILABLE VIA THE INTERNET IN GERMANY; IMPLICATIONS FOR PATIENT SAFETY ACROSS THE GLOBE
    Thomson, J.
    Reid, W. S.
    Pullen, H.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 254 - 255
  • [24] Chiroptical and vibrational spectroscopic study of genuine and counterfeit medicines containing tadalafil
    Kralik, Frantisek
    Jirmasek, Patrik
    Kuchar, Martin
    Setnicka, Vladimir
    CHIRALITY, 2018, 30 (05) : 560 - 567
  • [25] Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors
    E.Deconinck
    S.Andriessens
    J.L.Bothy
    P.Courselle
    J.O.De Beer
    JournalofPharmaceuticalAnalysis, 2014, 4 (04) : 250 - 257
  • [26] Counterfeit medicines: Report of a cross-sectional retrospective study in Iran
    Hosseini, S. A. R.
    Darbooy, Sh.
    Banihashemi, S. A. Tehrani
    Naseri, S. M.
    Dinarvand, R.
    PUBLIC HEALTH, 2011, 125 (03) : 165 - 171
  • [27] Regulations concerning data transparency-a comparison between the USA and Europe
    Quack, Christian
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2011, 105 (03): : 183 - 188
  • [28] Comparison of the international regulations for medical devices-USA versus Europe
    Fink, Matthias
    Akra, Bassil
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2023, 54
  • [29] Variation in the prices of oncology medicines across Europe and the implications for the future
    Godman, Brian
    Simoens, Steven
    Kurdi, Amanj
    Selke, Gisbert
    Yfantopoulos, John
    Hill, Andrew
    Gulbinovic, Jolanta
    Martin, Antony P.
    Timoney, Angela
    Gotham, Dzintars
    Wale, Janet
    Bochenek, Tomasz
    Krulichova, Iva Selke
    Allocati, Eleonora
    Hoxha, Iris
    Malaj, Admir
    Hierlander, Christian
    Nachtnebel, Anna
    Hamelinck, Wouter
    Mitkova, Zornitza
    Petrova, Guenka
    Laius, Ott
    Sermet, Catherine
    Langner, Irene
    Joppi, Roberta
    Jakupi, Arianit
    Poplavska, Elita
    Greiciute-Kuprijanov, Ieva
    Bonanno, Patricia Vella
    Piepenbrink, J. F.
    De Valk, Vincent
    Plisko, Robert
    Wladysiuk, Magdalene
    Markovic-Pekovic, Vanda
    Mardare, Ileana
    Novakovic, Tanja
    Parker, Mark
    Furst, Jurij
    Tomek, Dominik
    Banasova, Katarina
    Cortadellas, Merce Obach
    Zara, Corrine
    Pontes, Caridad
    Juhasz-Haverinen, Maria
    Skiold, Peter
    McTaggart, Stuart
    Wong-Rieger, Durhane
    Campbell, Stephen
    Hill, Ruaraidh
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2021, 10 (02): : 72 - 82
  • [30] Public health relevance of medicines developed under paediatric legislation in Europe and the USA: a systematic mapping study
    Volodina, Anna
    Jahn, Albrecht
    Jahn, Rosa
    BMJ PAEDIATRICS OPEN, 2024, 8 (01)